Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    Open Studies | "Huntington Disease"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
2 Recruiting Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Device: ACTIVA® PC neurostimulator (Model 37601)
3 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
4 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo
5 Recruiting Growth and Development of the Striatum in Huntington's Disease
Condition: Huntington's Disease
Intervention:
6 Recruiting Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Condition: Huntington's Disease
Intervention:
7 Recruiting Exercise Effects in Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Exercise training
8 Recruiting Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride
Condition: Huntington Disease
Interventions: Drug: Olanzapine;   Drug: Xenazine;   Drug: Tiapridal
9 Recruiting Study of Biomarkers That Predict the Evolution of Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Huntington patient evaluation;   Other: Healthy subject evaluation
10 Recruiting REGISTRY-JHD - an Observational Study of the European Huntington's Disease Network (EHDN)
Condition: Huntington Disease, Juvenile
Intervention:
11 Not yet recruiting PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
Condition: Huntington's Disease
Intervention: Device: Deep Brain Stimulation
12 Not yet recruiting Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Condition: Huntington's Disease
Intervention: Other: functional Imaging
13 Recruiting Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Condition: Huntington Disease
Intervention: Device: Eye-tracking
14 Recruiting REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)
Conditions: Huntington Disease;   Huntington's Disease
Intervention:
15 Recruiting Dynamic Neuroimaging Biomarkers in Huntington's Disease
Condition: Brain Neuroimaging Biomarkers in Huntington Disease
Intervention:
16 Recruiting A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: Triheptanoin oil;   Drug: Placebo
17 Not yet recruiting HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Condition: Huntington's Disease
Intervention:
18 Recruiting Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers
Condition: Huntington's Disease
Intervention: Radiation: Radioligand [18F]MNI-659
19 Recruiting A Clinical Study in Subjects With Huntington's Disease to Assess the Efficacy and Safety of Three Oral Doses of Laquinimod
Condition: Huntington's Disease
Interventions: Drug: Laquinimod;   Drug: Placebo
20 Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Condition: Huntington's Disease
Intervention: Drug: 20 mg BID of PF-02545920

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.